SONDRA LEE: Open Payments
NPI 1174041560 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 14 payments from 11 companies in 2025. Trend: 2023 $406 · 2024 $319 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Deciphera Pharmaceuticals Inc. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $20 |
| TAIHO ONCOLOGY, INC. | 1 | $16 |
Products named: IMFINZI, OJJAARA, QINLOCK, CARVYKTI, ULTOMIRIS, KEYTRUDA, Nubeqa, ELREXFIO.
Industry payments across AL — which companies pay providers there.
